Helix Biopharma Corp.
HBP.TO
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 742.97% | -79.10% | 51.49% | 475.92% | -92.41% |
| Total Receivables | -8.91% | -34.02% | -38.91% | 33.89% | -3.82% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 38.91% | -56.76% | 2.06% | 149.67% | -12.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 431.98% | -72.50% | 30.39% | 253.48% | -82.87% |
|
|
|||||
| Total Current Assets | 431.98% | -72.50% | 30.39% | 253.48% | -82.87% |
| Net Property, Plant & Equipment | 101.54% | -71.98% | -6.07% | -13.03% | -3.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 421.41% | -72.44% | 29.38% | 224.04% | -81.16% |
|
|
|||||
| Total Accounts Payable | 260.68% | 14.54% | -21.95% | 216.73% | -64.66% |
| Total Accrued Expenses | 0.07% | 8.17% | 97.33% | 32.60% | -3.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 22.44% | 11.62% | 4.39% | 142.96% | -50.83% |
|
|
|||||
| Total Current Liabilities | 22.44% | 11.62% | 4.39% | 142.96% | -50.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.44% | 11.62% | 4.39% | 142.96% | -50.83% |
|
|
|||||
| Common Stock & APIC | -2.22% | -1.13% | 1.16% | -1.82% | 4.46% |
| Retained Earnings | 3.09% | 0.24% | -2.05% | 1.78% | -4.27% |
| Treasury Stock & Other | -12.35% | 11.79% | 85.62% | -2.38% | -30.63% |
| Total Common Equity | 98.66% | -1,401.23% | 75.11% | -35.28% | -143.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 98.66% | -1,401.23% | 75.11% | -35.28% | -143.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 98.66% | -1,401.23% | 75.11% | -35.28% | -143.23% |
|
|
|||||